Cargando…
Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia
AIM: The aim of this study was to analyze the use of benzodiazepines in the period of 2003-2013 year in the Republic of Macedonia (MKD). METHOD: The study was cross sectional and analyzes the available data on the use of benzodiazepines in the country. This study used several sources of data: Statis...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Institute of Immunobiology and Human Genetics
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877776/ https://www.ncbi.nlm.nih.gov/pubmed/27275214 http://dx.doi.org/10.3889/oamjms.2015.004 |
_version_ | 1782433443845505024 |
---|---|
author | Petrushevska, Tatjana Velik Stefanovska, Vesna |
author_facet | Petrushevska, Tatjana Velik Stefanovska, Vesna |
author_sort | Petrushevska, Tatjana |
collection | PubMed |
description | AIM: The aim of this study was to analyze the use of benzodiazepines in the period of 2003-2013 year in the Republic of Macedonia (MKD). METHOD: The study was cross sectional and analyzes the available data on the use of benzodiazepines in the country. This study used several sources of data: Statistical Reports of the United Nations regarding the consumption of psychotropic substances; data from the Ministry of Health associated with the use of benzodiazepines (BZD), derived from reports of Ministry of Health stakeholders; Data extracted from the database of the Ministry of Health in the electronic database “My term” and Analysis of reports of Health Insurance Fund. RESULTS: The analysis for the period 2003-2013 showed that the most consumed drug in MKD from the group of BZD is Diazepam, with 54.8 and predominantly is use of diazepam of 5 mg with 59 %. According to the Health Insurance Fund, Diazepam is second most prescribed medicaments of all medicaments with marketing authorization in MKD. CONCLUSIONS: The analysis shows that the use of BZD in MKD is particularly high. Limited number of studies was performed for this kind of drugs relating to their effects; differences in use between genders; adult population. There is need for additional focused research that will contribute to developing a full picture of the situation. |
format | Online Article Text |
id | pubmed-4877776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Institute of Immunobiology and Human Genetics |
record_format | MEDLINE/PubMed |
spelling | pubmed-48777762016-06-06 Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia Petrushevska, Tatjana Velik Stefanovska, Vesna Open Access Maced J Med Sci Public Health AIM: The aim of this study was to analyze the use of benzodiazepines in the period of 2003-2013 year in the Republic of Macedonia (MKD). METHOD: The study was cross sectional and analyzes the available data on the use of benzodiazepines in the country. This study used several sources of data: Statistical Reports of the United Nations regarding the consumption of psychotropic substances; data from the Ministry of Health associated with the use of benzodiazepines (BZD), derived from reports of Ministry of Health stakeholders; Data extracted from the database of the Ministry of Health in the electronic database “My term” and Analysis of reports of Health Insurance Fund. RESULTS: The analysis for the period 2003-2013 showed that the most consumed drug in MKD from the group of BZD is Diazepam, with 54.8 and predominantly is use of diazepam of 5 mg with 59 %. According to the Health Insurance Fund, Diazepam is second most prescribed medicaments of all medicaments with marketing authorization in MKD. CONCLUSIONS: The analysis shows that the use of BZD in MKD is particularly high. Limited number of studies was performed for this kind of drugs relating to their effects; differences in use between genders; adult population. There is need for additional focused research that will contribute to developing a full picture of the situation. Institute of Immunobiology and Human Genetics 2015-03-15 2014-12-24 /pmc/articles/PMC4877776/ /pubmed/27275214 http://dx.doi.org/10.3889/oamjms.2015.004 Text en Copyright: © 2015 Tatjana Petrushevska, Vesna Velik Stefanovska. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Public Health Petrushevska, Tatjana Velik Stefanovska, Vesna Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia |
title | Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia |
title_full | Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia |
title_fullStr | Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia |
title_full_unstemmed | Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia |
title_short | Use of Medicines from the Group of Benzodiazepines in the Period of 2003-2013 Year in the Republic of Macedonia |
title_sort | use of medicines from the group of benzodiazepines in the period of 2003-2013 year in the republic of macedonia |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877776/ https://www.ncbi.nlm.nih.gov/pubmed/27275214 http://dx.doi.org/10.3889/oamjms.2015.004 |
work_keys_str_mv | AT petrushevskatatjana useofmedicinesfromthegroupofbenzodiazepinesintheperiodof20032013yearintherepublicofmacedonia AT velikstefanovskavesna useofmedicinesfromthegroupofbenzodiazepinesintheperiodof20032013yearintherepublicofmacedonia |